Menu

#Viridian

2 posts

Feed·
2 of 2 posts
Viridian Therapeutics, Inc. (VRDN) Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease Transcript
🖼️
0Read More

Viridian Therapeutics, Inc. (VRDN) Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease Transcript

Seeking Alpha·SA Transcripts·6 months ago
#YSq57X7Y
#source#chevron#alpha#research#call

From Seekingalpha RSS Feed: Viridian Therapeutics, Inc. (VRDN) Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease Transcript

15s